ArticleFrontiers in pharmacology2021

A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress

Yu-Jie Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.